|
|
|
Personalis Inc (NASDAQ: PSNL) |
|
Personalis Inc
PSNL's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Looking into Personalis Inc growth rates, revenue grew
by 5.53 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 1379
Medical Laboratories industry recorded
growth of revenues by 2.97 %
Personalis Inc net loss increased from $-13 millions, to $-16 millions in first quarter of 2025,
• More on PSNL's Growth
|
|
Personalis Inc
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 23.18 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
-0 |
|
PE TTM
|
|
Company's Price to Sales ratio is at 7.31.
Medical Laboratories industry's Price to Sales ratio is at 2.31.
• More on PSNL's Valuation
|
|
|
|
|
Personalis Inc
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 23.18 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
-0 |
|
PE TTM
|
|
Company's Price to Sales ratio is at 7.31.
Medical Laboratories industry's Price to Sales ratio is at 2.31.
Personalis Inc Price to Book Ratio is at 3.02 lower than Industry Avg. of 335.86. and higher than S&P 500 Avg. of 0.01
• More on PSNL's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
